<--- Back to Details
First PageDocument Content
Drug discovery / Pharmaceutical industry / Tuberculosis / Pharmaceutical sciences / Biomarker / Daylight saving time / Clinical research / Medicine / Pharmacology / Critical Path Institute
Date: 2014-04-22 02:57:01
Drug discovery
Pharmaceutical industry
Tuberculosis
Pharmaceutical sciences
Biomarker
Daylight saving time
Clinical research
Medicine
Pharmacology
Critical Path Institute

Add to Reading List

Source URL: www.stoptb.org

Download Document from Source Website

File Size: 1,67 MB

Share Document on Facebook

Similar Documents

THE BEST RESOURCE: HARMONIZING BIOMARKER TERMINOLOGY

DocID: 1vrpl - View Document

MEDIA INFORMATION Published: 00:01 hrs CEST Sunday, 22 April 2018 Gene linked to fatal outcomes in patients with P. aeruginosa bloodstream infection may be used as prognostic biomarker and treatment target Madrid, Spain:

DocID: 1vqLR - View Document

TUESDAY POSTER PRESENTATION TP01 - Cancer, Clinical and Translational Proteomics MO01-001 Verification of colorectal cancer biomarker candidates in plasma/serum extracellular vesicles by targeted proteomics Takeshi Tomon

DocID: 1v6qe - View Document

Stressed about Picking an Oxidative Damage Assay? A Guide to Finding the Right Biomarker to Detect in Your Application Oxidative stress can be evaluated directly by measuring reactive oxygen species (ROS) or indirectly b

DocID: 1v559 - View Document

Media Planet – Der Krebsratgeber http://www.krebsratgeber.at/praezisionsmedizin-smarte-biomarker-nanotechnologien-und-mehr

DocID: 1v1Po - View Document